Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families

European Journal of Human Genetics

Volumn 16, Issue 9, 2008, Pages 1135-1141

  de Snoo, Femke A ^a   Hottenga, Jouke Jan ^b   Gillanders, Elizabeth M ^c   Sandkuijl, Loudewijk A ^a   Jones, Mary Pat ^c   Bergman, Wilma ^a   van der Drift, Clasine ^a   van Leeuwen, Inge ^a   van Mourik, Lenny ^a   ter Huurne, Jeanet A C ^a   Frants, Rune R ^a   Willemze, Rein ^a   Breuning, Martijn H ^a   Trent, Jeffrey M ^d   Gruis, Nelleke A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P16;

ARTICLE; CANCER RISK; CHROMOSOME 7Q; CHROMOSOME BAND; CONTROLLED STUDY; DYSPLASTIC NEVUS; FEMALE; FOUNDER EFFECT; GENE DELETION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR;

CHROMOSOMES, HUMAN, PAIR 7; CYCLIN-DEPENDENT KINASE 6; DYSPLASTIC NEVUS SYNDROME; FEMALE; FOUNDER EFFECT; GENE DELETION; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE DETECTION; HUMANS; LINKAGE (GENETICS); MALE; MELANOMA; PEDIGREE; SKIN NEOPLASMS;

EID: 50149120124     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.72     Document Type: Article

References (26)

1. Skolnick MH, Cannon-Albright IA, Kamb A: Genetic predisposition to melanoma. Eur J Cancer 1994; 30A: 1991-1995.
2. Lynch HT, Frichot III BC, Lynch JF: Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978; 15: 352-356.
3. Kamb A, Gruis NA, Weaver-Feldhaus J et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
4. Foulkes WD, Flanders TY, Pollock PM, Hayward NK: The CDKN2A (p16) gene and human cancer. Mol Med 1997; 3: 5-20.
5. Kefford R, Bishop JN, Tucker M et al: Genetic testing for melanoma. Lancet Oncol 2002; 3: 653-654.
6. Hussussian CJ, Struewing JP, Goldstein AM et al: Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 5-21.
7. Cannon-Albright LA, Meyer Lj, Goldgar DE et al: Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 1994; 54: 6041-6044.
8. Bishop JA, Wachsmuth RC, Harland M et al: Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol 2000; 114: 28-33.
9. Hille ET, van Duijn E, Gruis NA, Rosendaal FR, Bergman w, Vandenbroucke JP: Excess cancer mottality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994. J Invest Dermatol 1998; 110: 788-792.
10. Gruis NA, Sandkuill LA, Weber JL et al: Linkage analysis in Dutch, familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count. Melanoma Res 1993; 3: 271-277.
11. Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W, Frants RR: CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res 1995; 5: 169-177.
12. Puig S, Ruiz A, Castel T et al: Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene. Hum Genet 1997; 101: 359-364.
13. Gruis NA, van der Velden PA, Sandkuljl LA et al: Homozygotes for CDKN2 (pl6) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995; 10: 351-353.
14. GAbecasis GR, Cherny SS, Cookson WO, Cardon LR: GRR: graphical representation of relationship errors. Bioinformatics 2001; 17 742-743.
15. Duffy DL: An integrated genetic map for linkage analysis. Behav Genet 2006; 36: 4-6.
16. Kong X, Murphy K, Rai T, He C, White PS, Matise TC: A combined linkage-physical map of the human genome. Am J Hum Genet 2004; 75: 1143-1148.
17. Lathrop GM, Lalouel JM: Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 1984; 36: 460-465.
18. Lander E, Kruglyak L: Genetic diGsection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
19. Bishop DT, Demenais F, Goldstein AM et al: Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94: 894-903.
20. Goldsteia AM, Struewing JP, Fraser MC, Smith MW, Tucker MA: Prospective risk of cancer In CDKN2A germline mutation carriers. J Med Genet 2004; 41: 421-424.
21. Cramer SF: Atypical histologic features in melanocytic nevi. Am J Dermatopathol 2001; 23: 160-161.
22. Easton DF, Cox GM, Macdonald AM, Ponder BA: Genetic susceptibility to naevi - a twin study. Br J Cancer 1991; 64: 1164-1167.
23. Wachsmuth RC, Gapt RM, Barrett JH. et al: Heritability and gene-environment interactions for melanocytic nevus density examined in a UK adolescent twin study. J Invest Dermatol 2001; 117: 348-352.
24. Goldstein AM, Tucker MA, Crutcher WA, Hartge P, Sagebiel RW: The inheritance pattern of dysplastic naevi in families of dysplastic naevus patients. Melanoma Res 1993; 3: 15-22.
25. Falchi M, Spector TD, Perks U, Kato BS, Bataille V: Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin - cohort. Hum Mol Genet 2006; 15: 2975-2979.
26. Zhu G, Montgomery GW, James MR et al: A genome-wide scan for naevus count: Linkage to CDKN2A and to other chromosome regions. Eur J Hum Genet 2007; 15: 94-102.